Spero Therapeutics (NASDAQ:SPRO) is scheduled to announce Q4 earnings results on Wednesday, March 13th, after market close. The consensus EPS Estimate is -$0.10 and the consensus Revenue Estimate is $...
Source LinkSpero Therapeutics (NASDAQ:SPRO) is scheduled to announce Q4 earnings results on Wednesday, March 13th, after market close. The consensus EPS Estimate is -$0.10 and the consensus Revenue Estimate is $...
Source Link
Comments